Comparative Outcomes of Catheter-Directed Thrombolysis versus AngioJet Pharmaco-mechanical Catheter-Directed Thrombolysis for Treatment of Acute Iliofemoral Deep Vein Thrombosis
Tao Kang,Yao-Liang Lu,Song Han,Xiao-Qiang Li
DOI: https://doi.org/10.1016/j.jvsv.2023.08.010
2023-08-26
Abstract:Objective The objective of this study was to compare the outcomes of PCDT+CDT vs. CDT alone for the treatment of acute iliofemoral DVT, summarizing the clinical experience, safety outcomes, and short-term and long-term efficacy. Methods This was a four-year retrospective, case-controlled study. A total of 95 consecutive acute symptomatic iliofemoral DVT patients with symptoms ≤ 7 days in duration involving the iliac and/or common femoral underwent endovascular interventions. Each was divided into two groups according to their clinical indications: the PCDT+CDT vs. CDT alone groups. Statistical analyses were used to compare clinical characteristics and outcomes between the two groups. Additionally, patients were followed up 3-36 months after treatment, and the proportion of PTS and moderate-severe PTS were analyzed using the Kaplan-Meier survival curve. Results A total of 95 consecutive patients were analyzed in this retrospective study, 51 of which were treated with CDT alone and 44 with PCDT+CDT. Between the two groups, in terms of immediate-term efficacy and safety, there were significant differences in the catheter retention time (60.64±12.04 hr. vs. 19.42±4.04 hr., P < 0.001), the required dosages of Urokinase(UK) (5.82±0.81 million units vs. 1.80±0.64 million units, P 95% lysis) (54.5% vs 68.6%, P = 0.047). Furthermore, during the follow-up period, there were significant differences in the incidence of PTS (Villalta scale≥5 or a venous ulcer) (47.0% vs. 27.7%, P = 0.037) and the proportion of moderate-severe PTS incidence at 12 months (15.7% vs. 4.5%, P = 0.024) and 24 months (35.3% vs. 11.4%, P = 0.016). Conclusions Compared with CDT alone, in the iliofemoral DVT subgroup with symptoms ≤ 7 days in duration, PCDT+CDT could significantly relieve early leg symptoms, shorten the days of hospitalization, reduce bleeding complications, promote long-term grade of venous patency, and decrease the occurrence of PTS and the proportion of moderate-severe PTS incidence. Thus, both short-term and long-term outcomes support the superiority of PCDT+CDT vs. CDT in this subgroup.
surgery,peripheral vascular disease